华恒生物：2025年前三季度净利润约1.68亿元

Group 1 - The core viewpoint of the article highlights Huaheng Biological's financial performance in Q3 2025, showing significant revenue growth but a decline in net profit and earnings per share [1] Group 2 - For the first three quarters of 2025, Huaheng Biological reported revenue of approximately 2.194 billion yuan, representing a year-on-year increase of 42.53% [1] - The net profit attributable to shareholders was approximately 168 million yuan, reflecting a year-on-year decrease of 1.34% [1] - The basic earnings per share were 0.67 yuan, which is a year-on-year decrease of 9.36% [1] Group 3 - As of the report date, Huaheng Biological's market capitalization stood at 8.6 billion yuan [2]